[Hormone therapy in renal adenocarcinoma].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000463:Algestone Acetophenide / Q000627:therapeutic use; D005260:Female; D005866:Gestonorone Caproate / Q000627:therapeutic use; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D009392:Nephrectomy; D011183:Postoperative Complications / Q000188:drug therapy; D013629:Tamoxifen / Q000627:therapeutic use
D013629:Tamoxifen; D008525:Medroxyprogesterone; D000463:Algestone Acetophenide; D005866:Gestonorone Caproate
L'ormonoterapia nell'adenocarcinoma renale.